MetLife Investment Management, LLC
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 1529735
Whippany, NJ
Position in VNDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$187,045
-$20,586 QoQ
Shares Held
30,563
+1.7% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. VNDA ranks #192 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in VNDA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $187,045 | 30,563 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $207,631 | 30,048 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $215,296 | 24,410 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $161,221 | 32,309 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $155,099 | 32,860 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $150,625 | 32,816 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $132,232 | 27,606 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $155,182 | 33,088 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $186,947 | 33,088 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $122,330 | 29,764 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $129,136 | 30,601 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $132,196 | 30,601 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $201,660 | 30,601 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $207,780 | 30,601 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $226,141 | 30,601 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $302,337 | 30,601 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $333,550 | 30,601 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $346,097 | 30,601 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $307,712 | 19,612 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $279,913 | 16,331 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 ALXN | — | 50,524 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $459,969 | 21,384 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 ALXN | — | 51,677 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $321,187 | 21,384 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 ALXN | — | 52,437 | Shares | Defined | 2024-05-24 | |
| 2020-12-31 | $319,775 | 24,336 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 ALXN | — | 54,847 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $235,085 | 24,336 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 ALXN | — | 57,269 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $278,403 | 24,336 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 ALXN | — | 57,040 | Shares | Defined | 2023-07-12 | |
| 2020-03-31 | $252,120 | 24,336 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||